Henriksen K, Karsdal MA, Martin TJ. Osteoclast-derived coupling factors in bone remodeling. Calcif Tissue Int. 2014;94(1):88–97.
Article
CAS
PubMed
Google Scholar
Matsuo K, Irie N. Osteoclast-osteoblast communication. Arch Biochem Biophys. 2008;473(2):201–9.
Article
CAS
PubMed
Google Scholar
Delaisse JM. The reversal phase of the bone-remodeling cycle: cellular prerequisites for coupling resorption and formation. BoneKEy Rep. 2014;3:561.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kikuta J, Ishii M. Osteoclast migration, differentiation and function: novel therapeutic targets for rheumatic diseases. Rheumatology. 2013;52(2):226–34.
Article
CAS
PubMed
Google Scholar
Lassen NE, Andersen TL, Ploen GG, Soe K, Hauge EM, Harving S, Eschen GET, Delaisse JM. Coupling of bone resorption and formation in real time: new knowledge gained from human Haversian BMUs. J Bone Miner Res. 2017;32(7):1395–405.
Article
CAS
PubMed
Google Scholar
Frost HM. The pathomechanics of osteoporoses. Clin Orthop Relat Res. 1985;(200):198-225.
Abdelgawad ME, Delaisse JM, Hinge M, Jensen PR, Alnaimi RW, Rolighed L, Engelholm LH, Marcussen N, Andersen TL. Early reversal cells in adult human bone remodeling: osteoblastic nature, catabolic functions and interactions with osteoclasts. Histochem Cell Biol. 2016;145(6):603–15.
Article
CAS
PubMed
Google Scholar
Andersen TL, Abdelgawad ME, Kristensen HB, Hauge EM, Rolighed L, Bollerslev J, Kjaersgaard-Andersen P, Delaisse JM. Understanding coupling between bone resorption and formation: are reversal cells the missing link? Am J Pathol. 2013;183(1):235–46.
Article
CAS
PubMed
Google Scholar
Asagiri M, Takayanagi H. The molecular understanding of osteoclast differentiation. Bone. 2007;40(2):251–64.
Article
CAS
PubMed
Google Scholar
Sucur A, Katavic V, Kelava T, Jajic Z, Kovacic N, Grcevic D. Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis. Int Orthop. 2014;38(9):1893–903.
Article
PubMed
Google Scholar
Carbone LD, Tylavsky FA, Cauley JA, Harris TB, Lang TF, Bauer DC, Barrow KD, Kritchevsky SB. Association between bone mineral density and the use of nonsteroidal anti-inflammatory drugs and aspirin: impact of cyclooxygenase selectivity. J Bone Miner Res. 2003;18(10):1795–802.
Article
CAS
PubMed
Google Scholar
Nakata K, Hanai T, Take Y, Osada T, Tsuchiya T, Shima D, Fujimoto Y. Disease-modifying effects of COX-2 selective inhibitors and non-selective NSAIDs in osteoarthritis: a systematic review. Osteoarthr Cartil. 2018;26:1263–73.
Article
CAS
Google Scholar
Iniguez MA, Pablos JL, Carreira PE, Cabre F, Gomez-Reino JJ. Detection of COX-1 and COX-2 isoforms in synovial fluid cells from inflammatory joint diseases. Br J Rheumatol. 1998;37(7):773–8.
Article
CAS
PubMed
Google Scholar
Jee WS, Ma YF. The in vivo anabolic actions of prostaglandins in bone. Bone. 1997;21(4):297–304.
Article
CAS
PubMed
Google Scholar
Woodiel FN, Fall PM, Raisz LG. Anabolic effects of prostaglandins in cultured fetal rat calvariae: structure–activity relations and signal transduction pathway. J Bone Miner Res. 1996;11(9):1249–55.
Article
CAS
PubMed
Google Scholar
Abate A, Yang G, Dennery PA, Oberle S, Schroder H. Synergistic inhibition of cyclooxygenase-2 expression by vitamin E and aspirin. Free Radic Biol Med. 2000;29(11):1135–42.
Article
CAS
PubMed
Google Scholar
Forder S, Voelker M, Lanas A. Gastrointestinal safety of aspirin for a high-dose, multiple-day treatment regimen: a meta-analysis of three randomized controlled trials. Drugs R D. 2016;16:263–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nelson S, Cloonan L, Kanakis AS, Fitzpatrick KM, Shideler KI, Perilla AS, Furie KL, Rost NS. Antecedent aspirin use is associated with less severe symptoms on admission for ischemic stroke. J Stroke Cerebrovasc Dis. 2016;25:2519–25.
Article
PubMed
Google Scholar
Schmidt M, Lamberts M, Olsen AM, Fosboll E, Niessner A, Tamargo J, Rosano G, Agewall S, Kaski JC, Kjeldsen K, Lewis BS, Torp-Pedersen C. Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology. Eur Heart J. 2016;37(13):1015–23.
Article
CAS
PubMed
Google Scholar
Wilson DG, Poole WE, Chauhan SK, Rogers BA. Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty. Bone Joint J. 2016;98-b(8):1056–61.
Article
CAS
PubMed
Google Scholar
Wood DM, Dargan PI, Jones AL. Measuring plasma salicylate concentrations in all patients with drug overdose or altered consciousness: is it necessary? Emerg Med J. 2005;22(6):401–3.
Article
CAS
PubMed
PubMed Central
Google Scholar
Radi ZA, Khan NK. Effects of cyclooxygenase inhibition on bone, tendon, and ligament healing. Inflamm Res. 2005;54(9):358–66.
Article
CAS
PubMed
Google Scholar
Lane NE, Bauer DC, Nevitt MC, Pressman AR, Cummings SR. Aspirin and nonsteroidal antiinflammatory drug use in elderly women: effects on a marker of bone resorption. The study of osteoporotic fractures research group. J Rheumatol. 1997;24(6):1132–6.
CAS
PubMed
Google Scholar
Cottrell J, O’Connor JP. Effect of non-steroidal anti-inflammatory drugs on bone healing. Pharmaceuticals. 2010;3(5):1668–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yamaza T, Miura Y, Bi Y, Liu Y, Akiyama K, Sonoyama W, Patel V, Gutkind S, Young M, Gronthos S, Le A, Wang CY, Chen W, Shi S. Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents. PLoS ONE. 2008;3(7):e2615.
Article
PubMed
PubMed Central
CAS
Google Scholar
Shi S, Yamaza T, Akiyama K. Is aspirin treatment an appropriate intervention to osteoporosis? Fut Rheumatol. 2008;3(6):499–502.
Article
PubMed
PubMed Central
Google Scholar
Gruber R, Schofnagl M, Karreth F, Fischer MB, Watzek G. The stable analog carbocyclic TXA2 but not platelet-released TXA2 induces osteoclast-like cell formation. Prostaglandins Leukotrienes Essent Fatty Acids. 2003;68(4):267–72.
Article
CAS
Google Scholar
Liu Y, Chen C, Liu S, Liu D, Xu X, Chen X, Shi S. Acetylsalicylic acid treatment improves differentiation and immunomodulation of SHED. J Dent Res. 2015;94(1):209–18.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen C, Akiyama K, Yamaza T, You YO, Xu X, Li B, Zhao Y, Shi S. Telomerase governs immunomodulatory properties of mesenchymal stem cells by regulating FAS ligand expression. EMBO Mol Med. 2014;6(3):322–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cao Y, Xiong J, Mei S, Wang F, Zhao Z, Wang S, Liu Y. Aspirin promotes bone marrow mesenchymal stem cell-based calvarial bone regeneration in mini swine. Stem Cell Res Ther. 2015;6:210.
Article
PubMed
PubMed Central
CAS
Google Scholar
Liu Y, Wang L, Kikuiri T, Akiyama K, Chen C, Xu X, Yang R, Chen W, Wang S, Shi S. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-gamma and TNF-alpha. Nat Med. 2011;17(12):1594–601.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shi S, Gronthos S, Chen S, Reddi A, Counter CM, Robey PG, Wang CY. Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Nat Biotechnol. 2002;20(6):587–91.
Article
CAS
PubMed
Google Scholar
Alfonso LF, Srivenugopal KS, Bhat GJ. Does aspirin acetylate multiple cellular proteins? (Review). Mol Med Rep. 2009;2(4):533–7.
CAS
PubMed
Google Scholar
Shen J, Hovhannisyan H, Lian JB, Montecino MA, Stein GS, Stein JL, Van Wijnen AJ. Transcriptional induction of the osteocalcin gene during osteoblast differentiation involves acetylation of histones h3 and h4. Mol Endocrinol. 2003;17(4):743–56.
Article
CAS
PubMed
Google Scholar
Zhan Y, He Z, Liu X, Miao N, Lin F, Xu W, Mu S, Mu H, Yuan M, Cao X, Jin H, Liu Z, Li Y, Zhang B. Aspirin-induced attenuation of adipogenic differentiation of bone marrow mesenchymal stem cells is accompanied by the disturbed epigenetic modification. Int J Biochem Cell Biol. 2018;98:29–42.
Article
CAS
PubMed
Google Scholar
Liu H, Li W, Liu Y, Zhang X, Zhou Y. Co-administration of aspirin and allogeneic adipose-derived stromal cells attenuates bone loss in ovariectomized rats through the anti-inflammatory and chemotactic abilities of aspirin. Stem Cell Res Ther. 2015;6:200.
Article
PubMed
PubMed Central
CAS
Google Scholar
Tang J, Xiong J, Wu T, Tang Z, Ding G, Zhang C, Wang S, Liu Y. Aspirin treatment improved mesenchymal stem cell immunomodulatory properties via the 15d-PGJ2/PPARgamma/TGF-beta1 pathway. Stem Cells Dev. 2014;23(17):2093–103.
Article
CAS
PubMed
PubMed Central
Google Scholar
Xu X, Zheng L, Yuan Q, Zhen G, Crane JL, Zhou X, Cao X. Transforming growth factor-beta in stem cells and tissue homeostasis. Bone Res. 2018;6:2.
Article
PubMed
PubMed Central
CAS
Google Scholar
Lin S, Lee WY, Huang M, Fu Z, Liang Y, Wu H, Xu L, Suen CW, Huang J, Wu T, Cui L, Li G. Aspirin prevents bone loss with little mechanical improvement in high-fat-fed ovariectomized rats. Eur J Pharmacol. 2016;791:331–8.
Article
CAS
PubMed
Google Scholar
Chow JW, Fox SW, Lean JM, Chambers TJ. Role of nitric oxide and prostaglandins in mechanically induced bone formation. J Bone Miner Res. 1998;13(6):1039–44.
Article
CAS
PubMed
Google Scholar
Vestergaard P, Steinberg TH, Schwarz P, Jorgensen NR. Use of the oral platelet inhibitors dipyridamole and acetylsalicylic acid is associated with increased risk of fracture. Int J Cardiol. 2012;160(1):36–40.
Article
PubMed
Google Scholar
Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med. 1998;104(5):413–21.
Article
CAS
PubMed
Google Scholar
Narumiya S, FitzGerald GA. Genetic and pharmacological analysis of prostanoid receptor function. J Clin Invest. 2001;108(1):25–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen MR, Dragoo JL. The effect of nonsteroidal anti-inflammatory drugs on tissue healing. Knee Surg Sports Traumatol Arthrosc. 2013;21(3):540–9.
Article
PubMed
Google Scholar
Lack WD, Fredericks D, Petersen E, Donovan M, George M, Nepola J, Smucker J, Femino JE. Effect of aspirin on bone healing in a rabbit ulnar osteotomy model. J Bone Joint Surg Am. 2013;95(6):488–96.
Article
PubMed
Google Scholar
Hoggatt J, Singh P, Sampath J, Pelus LM. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood. 2009;113(22):5444–55.
Article
CAS
PubMed
PubMed Central
Google Scholar
Goessling W, North TE, Loewer S, Lord AM, Lee S, Stoick-Cooper CL, Weidinger G, Puder M, Daley GQ, Moon RT, Zon LI. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell. 2009;136(6):1136–47.
Article
CAS
PubMed
PubMed Central
Google Scholar
Agas D, Marchetti L, Capitani M, Sabbieti MG. The dual face of parathyroid hormone and prostaglandins in the osteoimmune system. Am J Physiol Endocrinol Metab. 2013;305(10):E1185–94.
Article
CAS
PubMed
Google Scholar
Agas D, Marchetti L, Hurley MM, Sabbieti MG. Prostaglandin F2alpha: a bone remodeling mediator. J Cell Physiol. 2013;228(1):25–9.
Article
CAS
PubMed
Google Scholar
Raisz LG, Fall PM, Petersen DN, Lichtler A, Kream BE. Prostaglandin E2 inhibits alpha 1(I)procollagen gene transcription and promoter activity in the immortalized rat osteoblastic clonal cell line Py1a. Mol Endocrinol. 1993;7(1):17–22.
CAS
PubMed
Google Scholar
Chikazu D, Li X, Kawaguchi H, Sakuma Y, Voznesensky OS, Adams DJ, Xu M, Hoshio K, Katavic V, Herschman HR, Raisz LG, Pilbeam CC. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. J Bone Miner Res. 2002;17(8):1430–40.
Article
CAS
PubMed
Google Scholar
Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O’Keefe RJ. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest. 2002;109(11):1405–15.
Article
CAS
PubMed
PubMed Central
Google Scholar
Minamizaki T, Yoshiko Y, Kozai K, Aubin JE, Maeda N. EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures. Bone. 2009;44(6):1177–85.
Article
CAS
PubMed
Google Scholar
Machwate M, Harada S, Leu CT, Seedor G, Labelle M, Gallant M, Hutchins S, Lachance N, Sawyer N, Slipetz D, Metters KM, Rodan SB, Young R, Rodan GA. Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2). Mol Pharmacol. 2001;60(1):36–41.
Article
CAS
PubMed
Google Scholar
Graham S, Gamie Z, Polyzois I, Narvani AA, Tzafetta K, Tsiridis E, Helioti M, Mantalaris A, Tsiridis E. Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing: in vivo and in vitro evidence. Expert Opin Investig Drugs. 2009;18(6):746–66.
Article
PubMed
CAS
Google Scholar
Nakagawa K, Imai Y, Ohta Y, Takaoka K. Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation. Bone. 2007;41(4):543–8.
Article
CAS
PubMed
Google Scholar
Snijdewint FG, Kalinski P, Wierenga EA, Bos JD, Kapsenberg ML. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol (Baltimore, Md.: 1950). 1993;150(12):5321–9.
CAS
Google Scholar
Tokuda H, Kozawa O, Uematsu T. Interleukin (IL)-17 enhances prostaglandin F(2 alpha)-stimulated IL-6 synthesis in osteoblasts. Prostaglandins Leukotrienes Essent Fatty Acids. 2002;66(4):427–33.
Article
CAS
Google Scholar
Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 1999;20(3):345–57.
Article
CAS
PubMed
Google Scholar
Wang JS. Basic fibroblast growth factor for stimulation of bone formation in osteoinductive or conductive implants. Acta Orthop Scand. 1996;269:1–33.
Article
CAS
Google Scholar
Xie C, Liang B, Xue M, Lin AS, Loiselle A, Schwarz EM, Guldberg RE, O’Keefe RJ, Zhang X. Rescue of impaired fracture healing in COX-2−/− mice via activation of prostaglandin E2 receptor subtype 4. Am J Pathol. 2009;175(2):772–85.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cottrell JA, O’Connor JP. Pharmacological inhibition of 5-lipoxygenase accelerates and enhances fracture-healing. J Bone Joint Surg Am. 2009;91(11):2653–65.
Article
PubMed
Google Scholar
Maxis K, Delalandre A, Martel-Pelletier J, Pelletier JP, Duval N, Lajeunesse D. The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating protein. Arthritis Res Ther. 2006;8(6):R181.
Article
PubMed
PubMed Central
CAS
Google Scholar
Einhorn TA, Majeska RJ, Rush EB, Levine PM, Horowitz MC. The expression of cytokine activity by fracture callus. J Bone Miner Res. 1995;10(8):1272–81.
Article
CAS
PubMed
Google Scholar
Hausman MR, Schaffler MB, Majeska RJ. Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone. 2001;29(6):560–4.
Article
CAS
PubMed
Google Scholar
McCarty MF, Block KI. Preadministration of high-dose salicylates, suppressors of NF-kappaB activation, may increase the chemosensitivity of many cancers: an example of proapoptotic signal modulation therapy. Integr Cancer Ther. 2006;5(3):252–68.
Article
CAS
PubMed
Google Scholar
Somasundaram S, Sigthorsson G, Simpson RJ, Watts J, Jacob M, Tavares IA, Rafi S, Roseth A, Foster R, Price AB, Wrigglesworth JM, Bjarnason I. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Aliment Pharmacol Ther. 2000;14(5):639–50.
Article
CAS
PubMed
Google Scholar
Zeng R, Faccio R, Novack DV. Alternative NF-kappaB regulates RANKL-induced osteoclast differentiation and mitochondrial biogenesis via independent mechanisms. J Bone Miner Res. 2015;30(12):2287–99.
Article
CAS
PubMed
Google Scholar
Lemma S, Sboarina M, Porporato PE, Zini N, Sonveaux P, Di Pompo G, Baldini N, Avnet S. Energy metabolism in osteoclast formation and activity. Int J Biochem Cell Biol. 2016;79:168–80.
Article
CAS
PubMed
Google Scholar
Paul-Clark MJ, Van Cao T, Moradi-Bidhendi N, Cooper D, Gilroy DW. 15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation. J Exp Med. 2004;200(1):69–78.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rangaswami H, Schwappacher R, Marathe N, Zhuang S, Casteel DE, Haas B, Chen Y, Pfeifer A, Kato H, Shattil S, Boss GR, Pilz RB. Cyclic GMP and protein kinase G control a Src-containing mechanosome in osteoblasts. Sci Signal. 2010;3(153):ra91.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kalyanaraman H, Ramdani G, Joshua J, Schall N, Boss GR, Cory E, Sah RL, Casteel DE, Pilz RB. A novel, direct NO donor regulates osteoblast and osteoclast functions and increases bone mass in ovariectomized mice. J Bone Miner Res. 2016;32:46–59.
Article
PubMed
CAS
Google Scholar
Yang JY, Park MY, Park SY, Yoo HI, Kim MS, Kim JH, Kim WJ, Jung JY. Nitric oxide-induced autophagy in MC3T3-E1 cells is associated with cytoprotection via AMPK activation. Korean J Physiol Pharmacol. 2015;19(6):507–14.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hawley SA, Fullerton MD, Ross FA, Schertzer JD, Chevtzoff C, Walker KJ, Peggie MW, Zibrova D, Green KA, Mustard KJ, Kemp BE, Sakamoto K, Steinberg GR, Hardie DG. The ancient drug salicylate directly activates AMP-activated protein kinase. Science. 2012;336(6083):918–22.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kang H, Viollet B, Wu D. Genetic deletion of catalytic subunits of AMP-activated protein kinase increases osteoclasts and reduces bone mass in young adult mice. J Biol Chem. 2013;288(17):12187–96.
Article
CAS
PubMed
PubMed Central
Google Scholar
De Luna-Bertos E, Ramos-Torrecillas J, Garcia-Martinez O, Diaz-Rodriguez L, Ruiz C. Effect of aspirin on cell growth of human MG-63 osteosarcoma line. Sci World J. 2012;2012:834246.
Google Scholar
De Luna-Bertos E, Ramos-Torrecillas J, Garcia-Martinez O, Guildford A, Santin M, Ruiz C. Therapeutic doses of nonsteroidal anti-inflammatory drugs inhibit osteosarcoma MG-63 osteoblast-like cells maturation, viability, and biomineralization potential. Sci World J. 2013;2013:809891.
Google Scholar
Salari P, Abdollahi M. Controversial effects of non-steroidal anti-inflammatory drugs on bone: a review. Inflamm Allergy Drug Targets. 2009;8(3):169–75.
Article
CAS
PubMed
Google Scholar
Abukawa H, Phelps M, Jackson P, Smith RM, Vacanti JP, Kaban LB, Troulis MJ. Effect of ibuprofen on osteoblast differentiation of porcine bone marrow-derived progenitor cells. J Oral Maxillofac Surg. 2009;67(11):2412–7.
Article
PubMed
Google Scholar
Chang JK, Wang GJ, Tsai ST, Ho ML. Nonsteroidal anti-inflammatory drug effects on osteoblastic cell cycle, cytotoxicity, and cell death. Connect Tissue Res. 2005;46(4–5):200–10.
Article
CAS
PubMed
Google Scholar
Chang JK, Li CJ, Liao HJ, Wang CK, Wang GJ, Ho ML. Anti-inflammatory drugs suppress proliferation and induce apoptosis through altering expressions of cell cycle regulators and pro-apoptotic factors in cultured human osteoblasts. Toxicology. 2009;258(2–3):148–56.
Article
CAS
PubMed
Google Scholar
Arpornmaeklong P, Akarawatcharangura B, Pripatnanont P. Factors influencing effects of specific COX-2 inhibitor NSAIDs on growth and differentiation of mouse osteoblasts on titanium surfaces. Int J Oral Maxillofac Implants. 2008;23(6):1071–81.
PubMed
Google Scholar
Tornkvist H, Lindholm TS, Netz P, Stromberg L, Lindholm TC. Effect of ibuprofen and indomethacin on bone metabolism reflected in bone strength. Clin Orthop Relat Res. 1984;187:255–9.
Google Scholar
Burd TA, Lowry KJ, Anglen JO. Indomethacin compared with localized irradiation for the prevention of heterotopic ossification following surgical treatment of acetabular fractures. J Bone Joint Surg Am. 2001;83-A(12):1783–8.
Article
Google Scholar
O’Connor JP, Lysz T. Celecoxib, NSAIDs and the skeleton. Drugs Today (Barcelona, Spain: 1998). 2008;44(9):693–709.
Article
CAS
Google Scholar
Konstantinidis I, Papageorgiou SN, Kyrgidis A, Tzellos TG, Kouvelas D. Effect of non-steroidal anti-inflammatory drugs on bone turnover: an evidence-based review. Rev Recent Clin Trials. 2013;8(1):48–60.
Article
CAS
PubMed
Google Scholar
Bauer DC, Orwoll ES, Fox KM, Vogt TM, Lane NE, Hochberg MC, Stone K, Nevitt MC. Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. Study of osteoporotic fractures research group. J Bone Miner Res. 1996;11(1):29–35.
Article
CAS
PubMed
Google Scholar
van Staa TP, Leufkens HG, Cooper C. Use of nonsteroidal anti-inflammatory drugs and risk of fractures. Bone. 2000;27(4):563–8.
Article
PubMed
Google Scholar
Simon AM, O’Connor JP. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J Bone Joint Surg Am. 2007;89(3):500–11.
Article
PubMed
Google Scholar
Head JE, Bryant BJ, Grills BL, Ebeling PR. Effects of short-term use of ibuprofen or acetaminophen on bone resorption in healthy men: a double-blind, placebo-controlled pilot study. Bone. 2001;29(5):437–41.
Article
CAS
PubMed
Google Scholar
Alissa R, Sakka S, Oliver R, Horner K, Esposito M, Worthington HV, Coulthard P. Influence of ibuprofen on bone healing around dental implants: a randomised double-blind placebo-controlled clinical study. Eur J Oral Implantol. 2009;2(3):185–99.
PubMed
Google Scholar
Gineyts E, Mo JA, Ko A, Henriksen DB, Curtis SP, Gertz BJ, Garnero P, Delmas PD. Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis. Ann Rheum Dis. 2004;63(7):857–61.
Article
CAS
PubMed
PubMed Central
Google Scholar
Morton DJ, Barrett-Connor EL, Schneider DL. Nonsteroidal anti-inflammatory drugs and bone mineral density in older women: the Rancho Bernardo study. J Bone Miner Res. 1998;13(12):1924–31.
Article
CAS
PubMed
Google Scholar
Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritis. Calcif Tissue Int. 2006;79(2):84–94.
Article
CAS
PubMed
Google Scholar
Bonten TN, de Mutsert R, Rosendaal FR, Jukema JW, van der Bom JG, de Jongh RT, den Heijer M. Chronic use of low-dose aspirin is not associated with lower bone mineral density in the general population. Int J Cardiol. 2017;244:298–302.
Article
CAS
PubMed
Google Scholar
Barker AL, McNeil JJ, Seeman E, Ward SA, Sanders KM, Khosla S, Cumming RG, Pasco JA, Bohensky MA, Ebeling PR, Woods RL, Lockery JE, Wolfe R, Talevski J. A randomised controlled trial of low-dose aspirin for the prevention of fractures in healthy older people: protocol for the ASPREE-Fracture substudy. Inj Prev. 2016;22(4):297–301.
Article
PubMed
Google Scholar
Yates JE, Hadi Shah S, Blackwell JC. Clinical inquiries: do NSAIDs impede fracture healing? J Fam Pract. 2011;60(1):41–2.
PubMed
Google Scholar
Long J, Lewis S, Kuklo T, Zhu Y, Riew KD. The effect of cyclooxygenase-2 inhibitors on spinal fusion. J Bone Joint Surg Am. 2002;84-A(10):1763–8.
Article
Google Scholar
Tiseo BC, Namur GN, de Paula EJ, Junior RM, de Oliveira CR. Experimental study of the action of COX-2 selective nonsteroidal anti-inflammatory drugs and traditional anti-inflammatory drugs in bone regeneration. Clinics. 2006;61(3):223–30.
Article
PubMed
Google Scholar
Akman S, Gogus A, Sener N, Bilgic B, Aksoy B, Seckin F. Effect of diclofenac sodium on union of tibial fractures in rats. Adv Ther. 2002;19(3):119–25.
Article
CAS
PubMed
Google Scholar
Sudmann E, Dregelid E, Bessesen A, Morland J. Inhibition of fracture healing by indomethacin in rats. Eur J Clin Invest. 1979;9(5):333–9.
Article
CAS
PubMed
Google Scholar
Hogevold HE, Grogaard B, Reikeras O. Effects of short-term treatment with corticosteroids and indomethacin on bone healing. A mechanical study of osteotomies in rats. Acta Orthop Scand. 1992;63(6):607–11.
CAS
PubMed
Google Scholar
Mullis BH, Copland ST, Weinhold PS, Miclau T, Lester GE, Bos GD. Effect of COX-2 inhibitors and non-steroidal anti-inflammatory drugs on a mouse fracture model. Injury. 2006;37(9):827–37.
Article
PubMed
Google Scholar
Huo MH, Troiano NW, Pelker RR, Gundberg CM, Friedlaender GE. The influence of ibuprofen on fracture repair: biomechanical, biochemical, histologic, and histomorphometric parameters in rats. J Orthop Res. 1991;9(3):383–90.
Article
CAS
PubMed
Google Scholar
Altman RD, Latta LL, Keer R, Renfree K, Hornicek FJ, Banovac K. Effect of nonsteroidal antiinflammatory drugs on fracture healing: a laboratory study in rats. J Orthop Trauma. 1995;9(5):392–400.
Article
CAS
PubMed
Google Scholar
Lane N, Coble T, Kimmel DB. Effect of naproxen on cancellous bone in ovariectomized rats. J Bone Miner Res. 1990;5(10):1029–35.
Article
CAS
PubMed
Google Scholar
Lane N, Maeda H, Cullen DM, Kimmel DB. Cancellous bone behavior in hindlimb immobilized rats during and after naproxen treatment. Bone Miner. 1994;26(1):43–59.
Article
CAS
PubMed
Google Scholar
Jiang Y, Zhao J, Genant HK, Dequeker J, Geusens P. Bone mineral density and biomechanical properties of spine and femur of ovariectomized rats treated with naproxen. Bone. 1998;22(5):509–14.
Article
CAS
PubMed
Google Scholar
Wanders A, Heijde D, Landewe R, Behier JM, Calin A, Olivieri I, Zeidler H, Dougados M. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005;52(6):1756–65.
Article
CAS
PubMed
Google Scholar
Lionberger DR, Noble PC. Celecoxib does not affect osteointegration of cementless total hip stems. J Arthroplast. 2005;20(7 Suppl 3):115–22.
Article
Google Scholar
Bell NH, Hollis BW, Shary JR, Eyre DR, Eastell R, Colwell A, Russell RG. Diclofenac sodium inhibits bone resorption in postmenopausal women. Am J Med. 1994;96(4):349–53.
Article
CAS
PubMed
Google Scholar
Moore KD, Goss K, Anglen JO. Indomethacin versus radiation therapy for prophylaxis against heterotopic ossification in acetabular fractures: a randomised, prospective study. J Bone Joint Surg Br. 1998;80(2):259–63.
Article
CAS
PubMed
Google Scholar
Davis TR, Ackroyd CE. Non-steroidal anti-inflammatory agents in the management of Colles’ fractures. Br J Clin Pract. 1988;42(5):184–9.
CAS
PubMed
Google Scholar
Bichara J, Greenwell H, Drisko C, Wittwer JW, Vest TM, Yancey J, Goldsmith J, Rebitski G. The effect of postsurgical naproxen and a bioabsorbable membrane on osseous healing in intrabony defects. J Periodontol. 1999;70(8):869–77.
Article
CAS
PubMed
Google Scholar
Jeffcoat MK, Williams RC, Reddy MS, English R, Goldhaber P. Flurbiprofen treatment of human periodontitis: effect on alveolar bone height and metabolism. J Periodontal Res. 1988;23(6):381–5.
Article
CAS
PubMed
Google Scholar
Adolphson P, Abbaszadegan H, Jonsson U, Dalen N, Sjoberg HE, Kalen S. No effects of piroxicam on osteopenia and recovery after Colles’ fracture. A randomized, double-blind, placebo-controlled, prospective trial. Arch Orthop Trauma Surg. 1993;112(3):127–30.
Article
CAS
PubMed
Google Scholar